Evidence map›Paper›PMID 23911441›Full record

ReviewProgress in neuro-psychopharmacology & biological psychiatry2014

Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone?

Erik B Oleson, Roger Cachope, Aurelie Fitoussi, Joseph F Cheer

Abstract readReview
In one paragraph

Review in Progress in neuro-psychopharmacology & biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Erik B OlesonUniversity of Maryland, School of Medicine, 20 Penn St., Baltimore, MD 21201, United States; University of Colorado Denver, P.O. Box 173364, Denver, CO 80217, United States.
Roger CachopeUniversity of Maryland, School of Medicine, 20 Penn St., Baltimore, MD 21201, United States.
Aurelie FitoussiUniversity of Maryland, School of Medicine, 20 Penn St., Baltimore, MD 21201, United States.
Joseph F CheerUniversity of Maryland, School of Medicine, 20 Penn St., Baltimore, MD 21201, United States. Electronic address: jchee001@umaryland.edu.
University of Maryland, Baltimore · US

Funding

Cannabinoid Receptor Mechanisms in Accumbal Encoding of Extinction LearningR01DA025890 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI CHEER, JOSEPH F · 2008 to 2012
$1.3M
Endocannabinoids and the modulation of expectationR21DA033926 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI CHEER, JOSEPH F · 2012 to 2013
$226k
NIDA NIH HHS R01 DA025890NIDA NIH HHS R21 DA033926
6 · The paper itself

Abstract

Environmental and interoceptive cues are theorized to serve as 'signals' that motivate drug seeking and effects that may be augmented in the withdrawn state. Phasic dopamine release events are observed in the nucleus accumbens in response to such motivational salient stimuli and are thought to be necessary for drug-associated cues to trigger craving. We recently demonstrated how dopamine neurons encode stimuli conditioned to a negative event, as might occur during conditioned withdrawal, and stimuli predicting the avoidance of negative events, as might occur as an addict seeks out drugs to prevent withdrawal. In this review we first discuss how the subsecond dopamine release events might process conditioned withdrawal and drug seeking driven by negative reinforcement processes within the context of our dopamine data obtained during conditioned avoidance procedures. We next describe how the endocannabinoid system modulates phasic dopamine release events and how it might be harnessed to treat negative affective states in addiction. Specifically, we have demonstrated that endocannabinoids in the ventral tegmentum sculpt cue-induced accumbal surges in dopamine release and, therefore, may also be mobilized during drug withdrawal.

Indexed as

AnimalsDopamineEndocannabinoidsHumansNeurotransmitter AgentsNucleus AccumbensReinforcement, PsychologySubstance Withdrawal SyndromeVentral Tegmental AreaDopamineEndocannabinoidsNeurotransmitter AgentsAddictionAvoidanceDependenceDopamineEndocannabinoid

Identifiers

PMID23911441
PMCPMC3874071
OpenAlexW2021273830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.